The Amyloidosis Channel is supported with funding from Prothena (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ISA 2024 | Fostering a multidisciplinary approach to treating amyloidosis
Faizi Jamal, MD, City of Hope, Duarte, CA, discusses the importance of taking a multidisciplinary approach to treating amyloidosis, a disease affecting several organ systems. Dr Jamal highlights the importance of having cardiologists, neurologists, and nephrologists working together and communicating effectively to understand the interplay of various treatment strategies. This interview took place at the XIX International Symposium on Amyloidosis (ISA) in Rochester, MN.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Research supported by an award from Johnson & Johnson Innovation, LLC.
